Amerita Published Study Led by Renowned Medical Researcher Michael Rothkopf, MD, Shows Importance of Home Parenteral Nutrition on Outcomes, Cost

BrightSpring Health Services / December 9, 2022

A recent study by Amerita, a BrightSpring Health Services company, published in BMJ Nutrition, Prevention and Health shows the importance of home parenteral nutrition (HPN) for patients with intestinal failure requiring long-term nutritional support.

Led by renowned medical researcher and nutrition support physician Michael M. Rothkopf, MD, FACP, FACN, FTOS, the study was conducted on behalf of the Amerita Quality Improvement Project for HPN Patients (QIP-PN) to determine the impact of a Physician Nutrition Expert (PNE)-led multidisciplinary nutritional support team (MNST) on patient outcomes.

The study found that adhering to recommendations from a multidisciplinary nutritional support team (MNST) contributed to improved patients’ self-reported overall health and reduced adverse outcomes, hospitalization and the length of stay at the hospital.

“This new research will help us to more effectively treat patients who receive home parenteral nutrition support,” said Richard Iriye, Amerita’s CEO and President. “Amerita utilizes patient-centered research to help improve specialized care. These findings reinforce that MNST can have a positive impact on the quality of life and overall cost of HPN management.”

In addition to Dr. Rothkopf, several current and former members of the Amerita team contributed to the study, including Jaimie Haselhorst, RDN, LD, CNSC; Francine Gagliardotto, RPh; Allison Tallman, MS, RDN, CNSC; Debbie Stevenson, MS, RDN, CNSC; Rebecca Brown, RDN, CNSC; Andrew DePalma; and Dan Rosenberg. Non-Amerita contributors include Mohan Pant, Michael Saracco, Vladimir Proudan, Kishwar Shareef, and Nudrat Ayub.

The full study can be found here.

Share this

Filed under: BrightSpring Health Services, Media Hub, Pharmacy Solutions

Back to Media Hub